TREM2 and Alzheimer disease: Microglial activity in a mouse animal model of AD was focused in the vicinity of Aβ plaques and was associated with increased expression of phagocytic regulating factors such as TREM2 and CTSD, which improved the Aβ clearance and thus reduced neurotoxicity to neural cells [70].